Monthly Archives: November 2023

Canadian officials trace Salmonella outbreak to raw pet food; 40 patients confirmed

Canadian officials report that an outbreak of Salmonella infections in people has been traced to raw pet food and possibly contact with cattle. The Public Health Agency of Canada just released information about the outbreak, which began in July 2020. Since then, 40 people have been confirmed to be infected with the Salmonella I outbreak […]

Dr. Roach: Aspirin replaces blood thinner meds for a week due to biopsies

Dr. Keith Roach Dear Dr. Roach: I have been taking Plavix (clopidogrel) for 15 years because of a mild heart attack that resulted in three stents. Next month, I am having a prostate MRI and biopsy. The urologist told me to stop taking clopidogrel seven days prior and substitute 81 mg of aspirin in its place. I am very concerned […]

Study Reveals Link Between Neighborhood Environmental Burden and Risk of Cardiovascular Disease

BOSTON – A national study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) demonstrates that neighborhood exposure to environmental hazards is significantly associated with poor cardiovascular health across the United States. The study, presented at the American Heart Association Scientific Sessions and simultaneously published in JAMA Cardiology, found that greater cumulative environmental burden […]

Bloodstream Infection Diagnostics Get Boost from Oxford Nanopore, Day Zero Partnership

There are 11 million sepsis-related deaths every year, accounting for one in five deaths worldwide, according to the World Health Organization (WHO). In these severe infections, the risk of mortality can increase by the hour, making early and effective treatment paramount. However, current culture-based diagnostics—including those for antimicrobial susceptibility—can take days to return a result. […]

Antibiotic-Resistant Infections Rise in England After Covid Drop

(Bloomberg) — Cases of antibiotic-resistant infection increased in England last year, along with the number of related deaths, as experts warn that overuse and overexposure to antibiotics are helping breed resistant bacterial strains.  The number of people diagnosed with antibiotic-resistant infections increased 4% in 2022, according to a report from the UK Health Security Agency. […]

Stolen Infiniti used in 2 aggravated robberies found with bullet holes, blood in driver’s seat

MEMPHIS, Tenn. (WMC) – Memphis police say a stolen two-door blue Infiniti Q60 was used in two aggravated robberies last week. Now, police are on the hunt for the two men who abandoned it. According to police, the Infiniti was stolen on Wednesday, November 8 off Powers Road in Raleigh. The car has a handicap […]

Nick Jonas says Priyanka Chopra can access his blood sugar levels, knows ‘what to do in any scenario’

ByHT Entertainment Desk Nov 15, 2023 08:22 AM IST Share Via Copy Link Nick Jonas suffers from Type 1 diabetes and alerts Priyanka Chopra, when his blood sugar level is down. He also talked about explaining the condition to Malti. American singer-actor Nick Jonas has opened up about managing his Type 1 diabetes and also […]

Vicki Notaro: ‘I started taking blood pressure medication

When Vicki Notaro began to get consistently high blood pressure readings, caused by a genetic predisposition, she was tempted to ignore the problem — but soon realised she had to take action to protect her future self Vicki Notaro. Photo: Evan Doherty Vicki Notaro Yesterday at 03:30 I used to dread going to the doctor, […]

U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer (NSCLC)

PRINCETON, N.J.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Augtyro™ (repotrectinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).1 Administered as an oral therapy, Augtyro is a tyrosine kinase inhibitor (TKI) targeting ROS1 oncogenic fusions.1 The […]

Foundation Medicine Announces Collaboration with Pierre Fabre Laboratories to Develop Companion Diagnostics in Non-Small Cell Lung Cancer

CAMBRIDGE, Mass. & CASTRES, France–(BUSINESS WIRE)– Foundation Medicine, Inc., and Pierre Fabre Laboratories today announced a collaboration to develop Foundation Medicine’s high-quality genomic tests, FoundationOne®CDx and FoundationOne®Liquid CDx, as companion diagnostics for new targeted therapies to treat patients with non-small cell lung cancer (NSCLC). The companies will work collaboratively to seek the regulatory approval for […]